![Nicholas Plummer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Plummer
Consigliere Generale presso
VOLITIONRX LIMITED
Patrimonio netto: 8 838 $ in data 31/08/2026
Profilo
Nicholas Plummer is currently Group General Counsel at VolitionRX Ltd. since 2021.
Former positions include Secretary & General Counsel at Ark Therapeutics Group Plc from 2004 to 2008, Secretary & General Counsel at Novacyt SA, Managing Counsel-Europe at Patheon France SAS from 2013 to 2021, and a role at Ashurst Morris Crisp from 2004 to 2007.
Education includes a graduate degree from The University of Reading.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VOLITIONRX LTD 0,15% | 17/03/2026 | 20.363 ( 0,15% ) | 8 838 $ | 31/08/2026 |
Posizioni attive di Nicholas Plummer
| Società | Posizione | Inizio |
|---|---|---|
| VOLITIONRX LIMITED | Consigliere Generale | 01/11/2021 |
Precedenti posizioni note di Nicholas Plummer
| Società | Posizione | Fine |
|---|---|---|
Patheon France SAS
 Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2021 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Consigliere Generale | 01/01/2008 |
| NOVACYT | Consigliere Generale | - |
Formazione di Nicholas Plummer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
28
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VolitionRX Ltd.
 VolitionRX Ltd. Medical SpecialtiesHealth Technology Develops blood tests to help diagnose a range of cancers and other diseases | Health Technology |
